Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
XRP Price Breaks Out from Symmetrical Triangle: Is $1 Target in Sight?

XRP Price Breaks Out from Symmetrical Triangle: Is $1 Target in Sight?

CoineditionCoinedition2024/07/29 16:00
By:Maxwell Mutuma
  • XRP breakout above $0.59 suggests a bullish trend as resistance at $0.64 and $0.72 are key levels to watch.
  • Weekly chart shows $0.65 as crucial resistance whereby breaking it could lead XRP to $0.80 and $1.00.
  • XRP’s recent 3.25% rise and breakout from a triangle pattern signal potential for further gains.

XRP has sparked excitement in the cryptocurrency community with its recent bullish breakout . An analysis by The Moon of the XRP/USDT chart on a 1-hour timeframe highlights a crucial technical development.

A symmetrical triangle pattern has formed, typically signaling a continuation of the current trend. The breakout from this pattern suggests a potential upward move, marking a significant shift for XRP.

The symmetrical triangle, characterized by converging trend lines, has been a reliable indicator of price movements. The recent breakout on the upside is a bullish signal, indicating that XRP might continue its ascent.

Key support levels include $0.59, which represents the lower boundary of the triangle, and $0.58, identified during a previous consolidation phase. These levels are crucial as they could offer support if the price experiences a pullback.

Resistance levels also play a critical role in the current analysis. The first notable resistance is around $0.64, aligning with previous price peaks within the triangle. The next significant target is $0.72, a potential price level following the breakout. This projection is based on the historical price action and the pattern’s behavior.

XRP Price Breaks Out from Symmetrical Triangle: Is $1 Target in Sight? image 0 XRP Price Breaks Out from Symmetrical Triangle: Is $1 Target in Sight? image 1

XRP/USD 1-hour price chart, Source: X

Volume is a key factor in confirming the bullish trend. An increase in trading volume accompanying the breakout would bolster the bullish outlook. However, it is important to watch for potential pullbacks. After breaching the $0.64 resistance, XRP might retest this level as new support before targeting $0.72.

Further analysis by Sheldon The Sniper, on the weekly chart for XRP/USDT on Binance, reveals a broader perspective. A long-term descending trend line, originating from the peak in 2021, has been a persistent resistance level. Recently, the price tested this trend line, marking a critical juncture. The outcome of this test could determine the next phase for XRP.

Key support levels on this longer timeframe include $0.40 and $0.50. These levels have consistently provided support in past price movements. On the resistance front, $0.65 is the immediate hurdle, closely tied to the descending trend line. 

XRP Price Breaks Out from Symmetrical Triangle: Is $1 Target in Sight? image 2 XRP Price Breaks Out from Symmetrical Triangle: Is $1 Target in Sight? image 3

XRP/USD weekly  price chart,Source: X

A successful breakout above this level could lead to targets of $0.80 and $1.00. The latter represents a significant psychological barrier.

For XRP to confirm a bullish reversal, breaking above the $0.65 resistance with substantial volume is crucial. Conversely, if the price fails to break this resistance, it may retreat to the support levels at $0.50 or $0.40.

Currently, XRP is trading at $0.629921 with a 24-hour trading volume of $1,595,754,405, reflecting a 3.25% increase in the last 24 hours.

Disclaimer: The information presented in this article is for informational and educational purposes only. The article does not constitute financial advice or advice of any kind. Coin Edition is not responsible for any losses incurred as a result of the utilization of content, products, or services mentioned. Readers are advised to exercise caution before taking any action related to the company.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

U.S. non-farm payrolls surge by 165,000 in October, far exceeding expectations! Unemployment rate unexpectedly drops to 4.1%, December rate hike expectations intensify

In October, US non-farm payrolls increased by 165,000, which is 2.5 times the Wall Street median forecast of 65,000 and represents an exceptionally strong deviation of about 5 standard deviations, exceeding the upper limit of all institutional forecast ranges. The unemployment rate unexpectedly fell from 4.2% to 4.1%, while the market had expected it to remain unchanged; average hourly wages also accelerated year-on-year growth to 3.1%. Meanwhile, the previous two months' non-farm payrolls were revised upwards by a total of 84,000. Following the release of the data, the yield on 2-year US Treasury bonds rose by 7 basis points, and the pricing of the probability of a Fed rate hike in December climbed to 70%.

华尔街见闻•2026/11/06 15:01

AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion

The valuation range discussed by potential investors has been lowered from the previous high of $2 trillion to between $1.2 trillion and $1.3 trillion, and some strategists have even suggested going below $1 trillion to ensure safety. In the face of significant market volatility and financial concerns such as quarterly losses, Anthropic is facing tough decisions, including a discounted valuation, reducing the size of the offering, or postponing the listing.

华尔街见闻•2026/11/06 13:42
AI Sell-off Hits Anthropic IPO, Potential Valuation Expected to Drop to $1.2–1.3 Trillion

Moderna Q3 revenue up 29% year-on-year, far exceeding expectations, raises full-year revenue growth guidance to 15%-25% | Earnings Report Insight

Moderna's Q3 revenue increased by 29% year-on-year to $1.31 billion, with profits significantly exceeding expectations. The company raised its 2026 revenue growth guidance to 15%-25%. The ramp-up of next-generation COVID-19 and flu vaccines, along with international market expansion, has driven performance improvement. Phase III data for the personalized cancer vaccine has also shown positive progress. The company is simultaneously advancing cost reduction and pipeline R&D, with year-end cash expectations significantly raised.

华尔街见闻•2026/11/06 13:23